In PAH, ECs produce vasoconstrictors, such as endothelin - 1 (ET - 1) and thromboxane, as well as vascular endothelial growth factor (VEGF) (Evans et al., 2021). The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.